First trimester maternal serum placental growth factor in trisomy 21 pregnancies

Prenatal Diagnosis

Volumn 30, Issue 5, 2010, Pages 449-453

  Cowans, N J ^a   Stamatopoulou, A ^a   Spencer, K ^a  

^a KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

Aneuploidy; First trimester; Free hCG; Nuchal translucency; PAPP A; PlGF; Screening; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOASSAY; MATERNAL AGE; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; TRISOMY 21;

BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES;

EID: 77951749828     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2496     Document Type: Article

References (21)

1. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. 2008. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32: 732-739.
2. Cowans NJ, Stamatopoulou A, Matwejew E, von Kaisenberg CS, Spencer K. 2010. First trimester placental growth factor (PlGF) as a marker for hypertensive disorders and SGA. Prenat Diagn (in press).
3. Debieve F, Moiset A, Thomas K, Pampfer S, Hubinont C. 2001. Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies. Mol Hum Reprod 7: 765-770. (Pubitemid 32734300)
4. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. 2008. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31: 493-502.
5. Lambert-Messerlian GM, Canick JA. 2004. Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia. Prenat Diagn 24: 876-880.
6. Maglione D, Guerriero V, Viglietto G, li-Bovi P, Persico MG. 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271.
7. Office of National Statistics. Birth Statistics.Series FM1, Number 31, Table 3.2, 2002.
8. Ong CY, Liao AW, Cacho AM, Spencer K, Nicolaides KH. 2001. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol 98: 608-611. (Pubitemid 32907455)
9. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. 2008. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 28: 1110-1115.
10. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. 1997. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18: 657-665. (Pubitemid 27448423)
11. Spencer K, Bindra R, Cacho AM, Nicolaides KH. 2004. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 24: 169-173. (Pubitemid 38428854)
12. Spencer K, Bindra R, Nicolaides KH. 2003a. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23: 851-855. (Pubitemid 37279873)
13. Spencer K, Bindra R, Nix AB, Heath V, Nicolaides KH. 2003b. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 22: 142-148. (Pubitemid 36976380)
14. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH. 2005. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 25: 365-369. (Pubitemid 40813777)
15. Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH. 2001. First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18. Prenat Diagn 21: 718-722. (Pubitemid 32929122)
16. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. 2003c. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 110: 281-286.
17. Su YN, Hsu JJ, Lee CN, Cheng WF, Kung CC, Hsieh FJ. 2002. Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome. Prenat Diagn 22: 8-12.
18. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. 2001. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184: 1267-1272. (Pubitemid 32434285)
19. Vuorela P, Hatva E, Lymboussaki A, et al. 1997. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56: 489-494. (Pubitemid 27081593)
20. Wright DE, Bray I. 2000. Estimating birth prevalence of Down's syndrome. J Epidemiol Biostat 5: 89-97.
21. Zaragoza E, Akolekar R, Poon LC, Pepes S, Nicolaides KH. 2009. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol 33: 382-386.